ARCHIVES

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Schmidt Attempted To Answer Critics

October 1, 1976

In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry

April 25, 1980

DOD To Reimburse Care On Clinical Trials In Three-Year Deal

February 9, 1996

NIAID Advisors Ok Women & Infants Study Continuation

February 21, 1992

DRCCA Board Okays Concepts Of New Cooperative Agreements For Smoking Program, Flow Cytometry For Bladder Cancer

October 28, 1983